临床医生的态度,意见和实践模式关于美国心脏外科手术中因诺托普的使用:一个多中心混合方法研究协议
Michael R Mathis1, Kamolnat Mirizzi2, Courtney J Burns2
1Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, Michigan, USA mathism@med.umich.edu.
BMJ open
|March 27, 2025
概括
心脏外科内类药物有风险和好处,但医院之间实践有很大差异. 这项研究调查了影响心脏手术患者内选择和使用因子的因素.
科学领域:
- 心脏病学 心脏病学
- 麻醉学 麻醉学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 对于手术患者而言,心脏内类药物存在重大风险-益处挑战.
- 在心脏手术中存在广泛的机构间差异.
- 有限的多中心数据存在于因诺托普选择和时间的决定因素.
研究的目的:
- 调查心脏外科手术中因诺托普选择和时间的决定因素.
- 了解临床医生关于异能药物使用的决策过程.
- 确定影响异能药物实践变化的因素.
主要方法:
- 多中心混合方法研究结合了定量和定性数据.
- 分析了来自美国30多家医院的电子健康记录.
- 调查和半结构面试与临床医生参与内的决策.
主要成果:
- 将收集关于异能药物使用模式的定量数据.
- 定性数据将探索临床医生的推理和实践改变的影响.
- 混合方法方法将产生对实践变化的元推理.
结论:
- 这些发现将阐明心脏外科手术中因诺托普实践变化的驱动因素.
- 这项研究旨在为因诺托普使用的质量改进计划提供信息.
- 了解实践的变化可以优化患者的护理和结果.
相关概念视频
01:26Heart Failure Drugs: Inotropic Agents
2.0K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
2.0K
01:29Cardiomyopathy V: Interprofessional Care
762
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
762